Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1631 1632 1641 1651
This examiner grants 52% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18038630 | ADIPOGENIC CELL COMPOSITIONS AND METHODS | Non-Final OA | Flagship Pioneering Innovations VI, LLC |
| 17433658 | COMPOSITIONS, METHODS, AND KITS FOR DELIVERY OF POLYRIBONUCLEOTIDES | Final Rejection | Flagship Pioneering Innovations VI, LLC |
| 17602987 | METHODS FOR TREATING INHERITED EYE DEFECTS | Final Rejection | The Regents of the University of California |
| 17496391 | METHODS AND SYSTEMS FOR IMPROVING CELLS FOR USE IN THERAPY | Non-Final OA | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA |
| 18000865 | DIRECT IN VIVO REPROGRAMMING USING TRANSCRIPTION FACTOR ETV2 GENE FOR ENDOTHELIAL CELL AND VESSEL FORMATION | Non-Final OA | EMORY UNIVERSITY |
| 17909705 | METHODS OF TREATING HYPERGLYCEMIA AND SUPPRESSING ONSET OF TYPE 1 DIABETES | Final Rejection | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY |
| 17906098 | MODIFIED ARRESTIN-1 TO ENHANCE PHOTORECEPTOR SURVIVAL IN RETINAL DISEASE | Non-Final OA | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED |
| 18011070 | ADAPTIVE NANOPARTICLE PLATFORMS FOR HIGH THROUGHPUT EXPANSION AND DETECTION OF ANTIGEN-SPECIFIC T CELLS | Final Rejection | The Johns Hopkins University |
| 17793506 | METHODS OF TREATING FRAGILE X SYNDROME WITH REELIN | Non-Final OA | UNIVERSITY OF SOUTH FLORIDA |
| 18035685 | SYNERGISTIC STEM CELL-BASED MEDICATION FOR TREATING MYOCARDIAL INFARCTION AND RELATED APPLICATION | Final Rejection | SOOCHOW UNIVERSITY |
| 18146109 | PRODUCTION METHOD FOR SYNOVIUM-DERIVED MESENCHYMAL STEM CELLS AND PRODUCTION METHOD FOR CELL PREPARATION FOR JOINT MEDICAL TREATMENT | Non-Final OA | National University Corporation Tokyo Medical and Dental University |
| 18098994 | Development of decellularized bovine bone graft | Final Rejection | University of Sharjah |
| 18267957 | PRE-TREATMENT OF MSC WITH PPARB/DELTA AGONIST FOR TREATMENT OF ISCHEMIA-REPERFUSION INJURY | Final Rejection | Centre Hospitalier Universitaire de Montpellier |
| 18041303 | A COMPOSITION COMPRISING MESENCHYMAL PRECURSOR OR STEM CELLS AND THEIR USE | Final Rejection | Mesoblast International Sárl |
| 17906160 | METHOD FOR TREATING INFLAMMATORY BOWEL DISEASE I | Non-Final OA | Mesoblast International Sárl |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy